1. The Oral Arguments and the Case as Presented by the Plaintiff-Appellees Debra Greenfield, J.D. Adjunct Assistant Professor UCLA Center for Society & Genetics

3. “…these claims are physical phenomenon, laws of nature, and abstract ideas, part of “the storehouse of knowledge of all men…free to all men and reserved exclusively to none.” Diamond v.Chakrabarty, 447 U.S. 303, 309 (quoting Funk Bros. Seed Co. v. Kalo Inoculant Co., 333 U. S. 127, 130 (1948)).

4. “ Myriad is losing the bigger battle… the entire industry will be reformatted… gene association patents as they exist today, won’t really matter.” Turna Ray, “At Appeals Hearing, Myriad Outlines Stance on BRCA IP Rights for Whole-Genome Sequencing,” Pharmacogenomics Reporter (April 4, 2011)available at http://www.genomeweb.com/dxpgx/appeals-hearing-myriad-outlines-stance-brca-ip-rights-whole-genome- sequencing?page=show, last visited April 11, 2011.), quoting George Churchhttp://www.genomeweb.com/dxpgx/appeals-hearing-myriad-outlines-stance-brca-ip-rights-whole-genome- sequencing?page=show